Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cyclobenzaprine Hydrochloride Tablets USP 5mg and 10mg. Cyclobenzaprin Hydrochloride Tablets is the...
[read full story]
Drug maker, Aurobindo Pharma * has received final approval from the US Food and Drug Administration (USFDA) to market (on prescription basis) Risperidone drug, which would be available in both tablet and oral dosage form. The...
Drug maker, Aurobindo Pharma has informed that it has secured approval from US Food and Drug Administration (USFDA) for marketing Fluconazole drug. Under the approval, the company will market and distribute the drug in the...
Hyderabad, Oct. 10 Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Cyclobenzaprine Hydrochloride tablets in 5 mg and 10 mg. The tablet is the generic...
Our Bureau, Mumbai Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (US FDA) to manufacture and market Fluconazole tablets 50mg, 100mg, 150mg and 200mg. Fluconazole tablets is the...
Mumbai (PTI): Aurobindo Pharma today said it has received approval from the US drug regulator for manufacturing and marketing two drugs -- Cyclobenzaprine Hydrochloride and Fluconazole Tablets -- in that country. In a filing to...
Aurobindo Pharma Ltd, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and...